Ubiquitination and proteasome-mediated degradation of BRCA1 and BARD1 during steroidogenesis in human ovarian granulosa cells.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular Endocrinology

• Publication date

  2007-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1210/ME.2006-0188PMID 17185394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Expression of Brcal is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice

  2007cited by this paper
• Tumor suppressor BRCA1 inhibits a breast cancer-associated promoter of the aromatase gene (CYP19) in human adipose stromal cells.

  2007cited by this paper
• BRCA1 negatively regulates the cancer-associated aromatase promoters I.3 and II in breast adipose fibroblasts and malignant epithelial cells.

  2006cited by this paper
• Modulation of aromatase expression by BRCA1: a possible link to tissue-specific tumor suppression

  2005cited by this paper
• Ubiquitin and ubiquitin-like proteins as multifunctional signals

  2005cited by this paper
• The orphan nuclear receptors NURR1 and NGFI-B modulate aromatase gene expression in ovarian granulosa cells: a possible mechanism for repression of aromatase expression upon luteinizing hormone surge.

  2005cited by this paper
• Cell-nonautonomous induction of ovarian and uterine serous cystadenomas in mice lacking a functional Brca1 in ovarian granulosa cells.

  2005influential reference
• Regulation of the estrogen-inducible gene expression profile by the breast cancer susceptibility gene BRCA1.

  2005cited by this paper
• The bone morphogenetic protein system in mammalian reproduction.

  2004cited by this paper
• Estrogen receptor mutations in human disease.

  2004cited by this paper
• Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression*

  2004cited by this paper
• Ubiquitin and breast cancer

  2004cited by this paper
• Follicle-stimulating Hormone Activation of Hypoxia-inducible Factor-1 by the Phosphatidylinositol 3-Kinase/AKT/Ras Homolog Enriched in Brain (Rheb)/Mammalian Target of Rapamycin (mTOR) Pathway Is Necessary for Induction of Select Protein Markers of Follicular Differentiation*

  2004cited by this paper
• Mass Spectrometric and Mutational Analyses Reveal Lys-6-linked Polyubiquitin Chains Catalyzed by BRCA1-BARD1 Ubiquitin Ligase*

  2004cited by this paper
• BRCA1 : BARD1 induces the formation of conjugated ubiquitin structures, dependent on K6 of ubiquitin, in cells during DNA replication and repair.

  2004cited by this paper
• BRCA1 and BRCA2: 1994 and beyond

  2004cited by this paper
• The multiple nuclear functions of BRCA1: transcription, ubiquitination and DNA repair.

  2003cited by this paper
• Enhancement of BRCA1 E3 Ubiquitin Ligase Activity through Direct Interaction with the BARD1 Protein*

  2003cited by this paper
• Mono- Versus Polyubiquitination: Differential Control of p53 Fate by Mdm2

  2003cited by this paper
• Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2

  2003cited by this paper
• Follicle-stimulating hormone and insulin-like growth factor I synergistically induce up-regulation of cartilage link protein (Crtl1) via activation of phosphatidylinositol-dependent kinase/Akt in rat granulosa cells.

  2003cited by this paper
• Follicle-stimulating hormone promotes nuclear exclusion of the forkhead transcription factor FoxO1a via phosphatidylinositol 3-kinase in porcine granulosa cells.

  2003cited by this paper
• Follicle-stimulating Hormone Activates Extracellular Signal-regulated Kinase but Not Extracellular Signal-regulated Kinase Kinase through a 100-kDa Phosphotyrosine Phosphatase*

  2003influential reference
• The BRCA1/BARD1 Heterodimer Assembles Polyubiquitin Chains through an Unconventional Linkage Involving Lysine Residue K6 of Ubiquitin*

  2003cited by this paper
• Development and validation of a new monoclonal antibody to mammalian aromatase.

  2002cited by this paper
• Aromatase--a brief overview.

  2002cited by this paper
• Gene expression profiling predicts clinical outcome of breast cancer

  2002cited by this paper
• Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

  2002cited by this paper
• Regulation of rat Sertoli cell function by FSH: possible role of phosphatidylinositol 3-kinase/protein kinase B pathway.

  2002cited by this paper
• BARD1 Induces BRCA1 Intranuclear Foci Formation by Increasing RING-dependent BRCA1 Nuclear Import and Inhibiting BRCA1 Nuclear Export*

  2002cited by this paper
• The BRCA1/BARD1 heterodimer, a tumor suppressor complex with ubiquitin E3 ligase activity.

  2002cited by this paper
• Autoubiquitination of the BRCA1·BARD1 RING Ubiquitin Ligase*

  2002cited by this paper
• Follicle-stimulating hormone amplifies insulin-like growth factor I-mediated activation of AKT/protein kinase B signaling in immature rat Sertoli cells.

  2002cited by this paper
• Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations.

  2002cited by this paper
• Ubiquitin and proteasomes: Themes and variations on ubiquitylation

  2001cited by this paper
• The RING Heterodimer BRCA1-BARD1 Is a Ubiquitin Ligase Inactivated by a Breast Cancer-derived Mutation*

  2001cited by this paper
• Mechanisms of estrogen action.

  2001cited by this paper
• Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor.

  2001cited by this paper
• BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

  2001cited by this paper
• Role of direct interaction in BRCA1 inhibition of estrogen receptor activity

  2001cited by this paper
• Estrogens and cell-cycle regulation in breast cancer.

  2001cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society

  2000cited by this paper
• Follicle-Stimulating hormone (FSH) stimulates phosphorylation and activation of protein kinase B (PKB/Akt) and serum and glucocorticoid-lnduced kinase (Sgk): evidence for A kinase-independent signaling by FSH in granulosa cells.

  2000cited by this paper
• In search of the tumour-suppressor functions of BRCA1 and BRCA2

  2000cited by this paper
• Molecular portraits of human breast tumours

  2000cited by this paper
• Paracrine actions of growth differentiation factor-9 in the mammalian ovary.

  1999cited by this paper
• BRCA1 inhibition of estrogen receptor signaling in transfected cells.

  1999cited by this paper
• A functional bone morphogenetic protein system in the ovary.

  1999cited by this paper
• Localization of human BRCA1 and its loss in high-grade, non-inherited breast carcinomas

  1999cited by this paper
• Impairing follicle-stimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance.

  1998cited by this paper
• Brca1 and Brca2 expression patterns in mitotic and meiotic cells of mice

  1998cited by this paper
• Murine oocytes suppress expression of luteinizing hormone receptor messenger ribonucleic acid by granulosa cells.

  1997cited by this paper
• Developmental expression of Brca2 colocalizes with Brca1 and is associated with proliferation and differentiation in multiple tissues.

  1997cited by this paper
• Brca1 is expressed independently of hormonal stimulation in the mouse ovary.

  1997cited by this paper
• Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

  1997cited by this paper
• BRCA1 is a component of the RNA polymerase II holoenzyme.

  1997cited by this paper
• Localization of BRCA1 and a splice variant identifies the nuclear localization signal

  1997influential reference
• Expression of aromatase in the ovary: down-regulation of mRNA by the ovulatory luteinizing hormone surge.

  1997cited by this paper
• Identification of a RING protein that can interact in vivo with the BRCA1 gene product

  1996cited by this paper
• BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

  1996cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Expression of Brca1 is associated with terminal differentiation of ectodermally and mesodermally derived tissues in mice.

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Relationship between the developmental programs controlling nuclear and cytoplasmic maturation of mouse oocytes.

  1994cited by this paper
• Hormonal control of gene expression in the ovary.

  1994cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Expression of mRNA species encoding steroidogenic enzymes in the rat ovary.

  1991cited by this paper
• Site of action of androgens on follicle-stimulating hormone-induced aromatase activity in cultured rat granulosa cells.

  1984cited by this paper
• In the Netherlands

  1961cited by this paper

• Regulation of placental development and function by ubiquitination

  2025cites this paper
• P62 promotes FSH-induced antral follicle formation by directing degradation of ubiquitinated WT1

  2024cites this paper
• The Role of Genetic Mutations in Mitochondrial-Driven Cancer Growth in Selected Tumors: Breast and Gynecological Malignancies

  2023cites this paper
• BRCA1 deficiency in triple-negative breast cancer: Protein stability as a basis for therapy.

  2022cites this paper
• Regulation of BRCA1 stability through the tandem UBX domains of isoleucyl-tRNA synthetase 1

  2022cites this paper
• CRL4-DCAF8L2 E3 ligase promotes ubiquitination and degradation of BARD1.

  2022cites this paper
• The fellowship of the RING: BRCA1, its partner BARD1 and their liaison in DNA repair and cancer.

  2021cites this paper
• SIRT2 promotes BRCA1-BARD1 heterodimerization through deacetylation

  2021cites this paper
• BRCA1 degradation in response to mitochondrial damage in breast cancer cells

  2021cites this paper
• The BRCA1/BARD1 ubiquitin ligase and its substrates.

  2021cites this paper
• Cavin3 released from caveolae interacts with BRCA1 to regulate the cellular stress response

  2020cites this paper
• LINC00152 promotes Ovarian tumor progression and Predicts Poor Prognosis by inhibiting the  ubiquitination of BCL6

  2020cites this paper
• LINC00152 Promotes Tumor Progression and Predicts Poor Prognosis by Stabilizing BCL6 From Degradation in the Epithelial Ovarian Cancer

  2020cites this paper
• Estrogen receptor alpha, G‐protein coupled estrogen receptor 1, and aromatase: Developmental, sex, and region‐specific differences across the rat caudate–putamen, nucleus accumbens core and shell

  2020cites this paper
• Possible Mechanisms for Maintenance and Regression of Corpus Luteum Through the Ubiquitin-Proteasome and Autophagy System Regulated by Transcriptional Factors

  2019influential citation
• RETRACTED: Structural analysis of BRCA1 reveals modification hotspot

  2017influential citation
• Breast cancer predisposition gene brca1, pathogenic c61g mutation in mice: synthetic viability in DNA repair and tumour development

  2016cites this paper
• 53BP1 ablation rescues genomic instability in mice expressing ‘RING‐less’ BRCA1

  2016cites this paper
• Breast cancer 1 (BRCA1)-deficient embryos develop normally but are more susceptible to ethanol-initiated DNA damage and embryopathies☆

  2015cites this paper
• Genetics of androgen metabolism in women with infertility and hypoandrogenism

  2015cites this paper
• HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.

  2014cites this paper
• HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway.

  2014cites this paper
• Stabilization of the transcription factor Foxp3 by the deubiquitinase USP7 increases Treg-cell-suppressive capacity.

  2013cites this paper
• The F-box Protein FBXO44 Mediates BRCA1 Ubiquitination and Degradation*

  2012cites this paper
• The C-terminal Proteolytic Fragment of the Breast Cancer Susceptibility Type 1 Protein (BRCA1) Is Degraded by the N-end Rule Pathway*

  2012cites this paper
• BRCA1/BARD1 complex interacts with steroidogenic factor 1--A potential mechanism for regulation of aromatase expression by BRCA1.

  2011cites this paper
• The BRCA1 ubiquitin ligase and homologous recombination repair

  2011cites this paper
• BARD1 (BRCA1 associated RING domain 1)

  2011cites this paper
• The Prostaglandin Transporter Regulates Adipogenesis and Aromatase Transcription

  2011cites this paper
• HERC2 is an E3 ligase that targets BRCA1 for degradation.

  2010cites this paper
• HERC 2 Is an E 3 Ligase That Targets BRCA 1 for Degradation

  2010cites this paper
• The role of the cellular proteasome and ubiquitin in post-entry restriction of retroviruses by TRIM5alpha

  2009cites this paper
• EP2 and EP4 Receptors Regulate Aromatase Expression in Human Adipocytes and Breast Cancer Cells

  2008cites this paper
• Gender differences and estrogen effects in parkin null mice

  2008cites this paper
• Estrogens have neurotrophic effects on midbrain dopamine (DA) neurons, promoting the growth of tyrosine hydrox-

  2008cites this paper
• EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.

  2008cites this paper
• A Role of CREB in BRCA1 Constitutive Promoter Activity and Aromatase Basal Expression

  2008cites this paper
• Proteasomal Degradation of TRIM5α during Retrovirus Restriction

  2008cites this paper
• Post-translational regulation of FOXP3

  2006cites this paper